Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Biomaterials and biopharmaceuticals
PPD acquires Acurian to strengthen patient recruitment and retention services
Biomaterials and biopharmaceuticals : 28 August, 2013
Pharmaceutical Product Development (PPD) acquires Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
 
Nordion divests Targeted Therapies business to BTG
Biomaterials and biopharmaceuticals : 16 July, 2013
Nordion, a provider of products and services to the global health science market, completes the divestiture of the company's Targeted Therapies business to BTG for a cash purchase price of $200 million.
 
ThromboGenics partners Alcon to launch ophthalmic medicines in Denmark and Sweden
Biomaterials and biopharmaceuticals : 29 May, 2013
ThromboGenics, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, is partnering Alcon to launch JETREA in Denmark and Sweden, the third and fourth European markets where the product is now available.
 
Nordion signs contract manufacturing deal with Navidea Biopharmaceuticals for diagnostic imaging agent
Biomaterials and biopharmaceuticals : 17 May, 2013
Nordion signs a contract manufacturing agreement with Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals.
 
OncoSec collaborates with Smart Patients to create online community for patients
Biomaterials and biopharmaceuticals : 22 April, 2013
OncoSec Medical is one of the first to partner with Smart Patients: a new online community where patients with life-threatening conditions who are looking for or participating in clinical trials can share their feedback and experiences.
 
InVivo Therapeutics receives FDA approval for first human trial using biomaterials for traumatic spinal cord injury
Biomaterials and biopharmaceuticals : 08 April, 2013
The US Food and Drug Administration (FDA) has approved InVivo Therapeutics' Investigational Device Exemption (IDE) to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
 
Bone Therapeutics receives manufacturing authorisation to produce allogeneic bone cell therapy products
Biomaterials and biopharmaceuticals : 26 March, 2013
Bone Therapeutics receives both 'Tissue Establishment' and 'GMP' Accreditation for the manufacturing of the company's ALLOB allogeneic bone cell therapy product, being initially developed for the treatment of impaired fractures.
 
Medisse raises more funding for adhesion barrier solution
Biomaterials and biopharmaceuticals : 30 January, 2013
Medisse closes a Series B equity financing round of 2.6 milion euros for the clinical trial of the company's lead product FlexiSurge Adhesion Barrier.
 
Dyax agrees Kadmon strategic licensing agreement for DX-2400
Biomaterials and biopharmaceuticals : 21 September, 2012
Dyax is entering into a strategic licensing agreement with Kadmon which will see Kadmon being granted an exclusive worldwide license for the development and commercialization of the fully human monoclonal antibody DX-2400, a potent and selective antibody inhibitor of matrix metalloproteinase 14 (MMP-14).
 
SafeStitch Medical agrees with Herniamesh to distribute mesh
Biomaterials and biopharmaceuticals : 01 August, 2012
SafeStitch Medical is entering in a distribution agreement with Herniamesh, an Italian mesh manufacturer operating in the biomedical market, to distribute mesh used for inguinal and ventral hernia repair in the USA.
 
Prosonix partners Imperial College London to develop engineered combination respiratory medicines
Biomaterials and biopharmaceuticals : 06 July, 2012
Prosonix (Oxford, UK) signs a Collaborative Research Agreement with Imperial College London to accelerate the development of engineered Multi-component Particles (MCPs) as respiratory medicines.
 
Olympus unveils dissolvable post sinus surgery products
Biomaterials and biopharmaceuticals : 09 January, 2012
Olympus is adding a broad line of advanced, dissolvable sinus spacing and haemostat products to the company's extensive ENT product portfolio.
 
Cardium agrees deal for commercialization of Excellagen in South Korea
Biomaterials and biopharmaceuticals : 09 January, 2012
Cardium Therapeutics is entering into the company's first international agreement for the commercialization of Excellagen in the South Korean market.
 
Quintiles acquires VCG and Associates plus VCG Bio
Biomaterials and biopharmaceuticals : 21 October, 2011
Quintiles completes the acquisition of VCG and Associates and VCG BIO, based in Holliston, Massachusetts, and Cave Creek, Arizona, respectively.
 
Bio-compatible 3D printing material provides medical solutions
Biomaterials and biopharmaceuticals : 23 September, 2011
Objet launches a new bio-compatible 3D printing material (MED610) that combines bio-compatibility with high dimensional stability and clear transparency making it useful for PMMA simulation and a wide range of medical and dental applications - particularly the production of highly accurate, customised surgical guides.
 
Irvine Scientific begins industrial cell culture media shipments in Japan
Biomaterials and biopharmaceuticals : 25 August, 2011
Irvine Scientific, a member of JX Holdings group, begins shipping the first products manufactured to customers from its Industrial Cell Culture media production facility in Tokyo, Japan.
 
GE Healthcare plans acquisition of PAA Laboratories
Biomaterials and biopharmaceuticals : 18 August, 2011
GE Healthcare agrees to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.
 
Quintiles to fund an adaptive clinical trial to develop breast cancer therapies
Biomaterials and biopharmaceuticals : 18 April, 2011
Quintiles is to contribute a total of $2.6 million over four years to support I-SPY 2, an adaptive clinical trial designed to develop breast cancer therapies twice as quickly and at one-fifth the cost of current methods.
 
New spine sealant from Covidien is approved by the US FDA
Biomaterials and biopharmaceuticals : 15 April, 2011
Covidien’s DuraSeal Exact spine sealant is approved by the US Food and Drug Administration (FDA).
 
Surgical sealant receives CE Mark and targets lung resection surgery
Biomaterials and biopharmaceuticals : 12 January, 2011
Neomend receives the CE Mark for the company’s ProGEL PLATINUM Surgical Sealant.
 
Medtronic acquires Osteotech to boost regenerative biologics performance
Biomaterials and biopharmaceuticals : 19 November, 2010
Medtronic completes the acquisition of Osteotech, following payment of $6.50 per share in cash for each share of Osteotech stock, with a total transaction value of approximately $123 million.
 
Cephalon agrees funding deal with ChemGenex for omacetaxine for CML patients
Biomaterials and biopharmaceuticals : 26 October, 2010
Cephalon signs a convertible note subscription agreement with ChemGenex Pharmaceuticals, an Australian-based oncology focused biopharmaceutical company.
 
Novozymes offers free evaluation samples of Bacillus-based sodium hyaluronate
Biomaterials and biopharmaceuticals : 07 July, 2010
Novozymes Biopharma is offering its customers free evaluation samples of the company's award-winning Bacillus-based sodium hyaluronate.
 
AdvanSource’s polymer products comply with EC’s new TSE guidelines
Biomaterials and biopharmaceuticals : 10 February, 2010
AdvanSource Biomaterials, a developer of advanced polymer materials for a broad range of medical devices, declares that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth in European Council Decision 1999/534/EC.
 
PolyTherics to develop novel biopharmaceutical molecule
Biomaterials and biopharmaceuticals : 27 January, 2010
Leverton Licence Holdings (LLH), a wholly-owned subsidiary of CP2, is investing into a research programme to develop a novel biopharmaceutical molecule.
 
Pall acquires MicroReactor Technologies
Biomaterials and biopharmaceuticals : 14 January, 2010
Pall acquires MicroReactor Technologies(MRT), a privately held US biotechnology company. MRT has developed a reliable, easy-to-use and cost-effective miniature bioreactor technology platform.
 
Biomerix biomaterial manufacturing sites receive ISO 13485 recognition
Biomaterials and biopharmaceuticals : 16 June, 2009
Biomerix, a medical technologies company developing products using its novel Biomerix Biomaterial, a three-dimensional scaffold for biointegrative tissue repair, receives an ISO 13485 Certificate of Registration.
 
New cGMP facility produces bacillus-based hyaluronic acid
Biomaterials and biopharmaceuticals : 29 April, 2009
Novozymes Biopharma, part of Novozymes, is constructing a new cGMP facility at the company's existing site in Tianjin, China that will enable its novel form of Bacillus-based Hyaluronic Acid (bHA), HyaCare, to be used within the bio-medical and pharmaceutical industries.
 
Bioresorbable film receives US FDA pre-market approval for paediatric cardiac surgery
Biomaterials and biopharmaceuticals : 10 March, 2009
The US Food and Drug Administration (FDA) has approved the Pre-market Approval (PMA) application for SyntheMed’s REPEL-CV Adhesion Barrier for use in paediatric cardiac surgery patients.
 
Study spotlights the osteoconductive properties of Trabecular Metal Technology
Biomaterials and biopharmaceuticals : 26 February, 2009
Data has been released from an independent 10-year comparative clinical study that demonstrates the osteoconductive properties of Zimmer's Trabecular Metal Technology.
 
CPC Scientific to offer Sigma-Aldrich's PEPscreen custom peptide libraries
Biomaterials and biopharmaceuticals : 02 February, 2009
CPC Scientific, a leading provider of custom peptide synthesis, GMP peptides and peptide APIs has signed a distribution agreement with Sigma-Aldrich.
 
Parexel International opens Peru office to extend Latin American coverage
Biomaterials and biopharmaceuticals : 21 November, 2008
Parexel International has opened an office in Lima, Peru to provide regulatory consulting and clinical research capabilities.
 
SyntheMed receives FDA 510(k) clearance to market SinusShield bioresorbable membrane
Biomaterials and biopharmaceuticals : 20 November, 2008
SyntheMed has received FDA 510(k) clearance to market SinusShield, a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures.
 
Debiopharm partners Ecole Polytechnique Federale de Lausanne in stem cell project
Biomaterials and biopharmaceuticals : 03 September, 2008
Debiopharm Group has signed a research project agreement with the Ecole Polytechnique Federale de Lausanne (EPFL), which is aimed at the identifying novel small molecules and peptides that interfere with pathways controlling cell fate specification.
 
Telik's small molecule proteasome inhibitor programme demonstrates anticancer activity
Biomaterials and biopharmaceuticals : 22 August, 2008
Telik’s novel small molecule proteasome inhibitor programme has met a preclinical development milestone by demonstrating anticancer activity in preclinical models of human leukemia.
 
ETEX launches orthobiologic bone graft substitute
Biomaterials and biopharmaceuticals : 18 August, 2008
ETEX has launched an innovative orthobiologic called EquivaBone which is a bone graft substitute that remodels and is replaced with new bone during the healing process.
 
Tissue culture range overcomes in vitro cell culture difficulties
Biomaterials and biopharmaceuticals : 18 July, 2008
The Iwaki range of tissue culture products from Sterilin consists of standard non-treated and tissue culture treated ware and features a range of substrate coated products developed to combat problems associated with in vitro cell culture.
 
PolyTherics to collaborate with Alligator Bioscience to develop new biopharmaceuticals
Biomaterials and biopharmaceuticals : 16 June, 2008
PolyTherics and Alligator Bioscience have established a new alliance which will see both companies collaborate to explore the biological effects of the polymer-based technologies developed by PolyTherics on proteins optimised and provided by Alligator.
 
CardioTech forms new biomaterials subsidiary
Biomaterials and biopharmaceuticals : 02 June, 2008
CardioTech International has formed AdvanSource Biomaterials to conduct its business and align its name with its strategic focus.
 
Polytherics receives European patent for polymer complexation technology
Biomaterials and biopharmaceuticals : 28 May, 2008
Polytherics has been granted a European patent on the application of polymer complexation technology to improve drug efficacy.
 
ETEX agrees a supply deal with AlloSource for DBM powder
Biomaterials and biopharmaceuticals : 25 April, 2008
Advanced biomaterials company, ETEX has entered into a supply agreement with AlloSource which will see AlloSource provide ETEX with Demineralized Bone Matrix (DBM) powder to be mixed with ETEX's proprietary, nanocrystalline, fast setting calcium phosphate to form EquivaBone.
 
FDA fast tracks synthetic human secretin for pancreatic imaging
Biomaterials and biopharmaceuticals : 17 April, 2008
The US Food and Drug Administration (FDA) has granted Fast Track designation to the development programme for Repligen’s RG1068, synthetic human secretin, to improve the assessment of pancreatic duct structures by magnetic resonance imaging (MRI).
 
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo